Filing Flows › Healthcare Services Group (HCSG) › Stock forecast & fair value
Healthcare Services Group (HCSG) stock forecast and fair value
Healthcare Services Group (HCSG) trades at $24.28. 6 analysts' median price target is $26.00 (+7%), from $24.00 to $30.00. Across 18 valuation methods the middle fair value is $26.69 (+10%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $24.99 | $37.62 | $44.60 | +55% |
| P/E vs peers, weighted | $20.38 | $27.85 | $40.37 | +15% |
| P/E vs peers, matched | $24.12 | $37.62 | $45.07 | +55% |
| P/E vs peers, growth-adjusted | $19.38 | $27.81 | $39.89 | +15% |
| EV/Sales vs peers | $34.00 | $54.06 | $80.14 | +123% |
| EV/Sales vs peers, weighted | $37.69 | $52.50 | $64.87 | +116% |
| EV/Sales vs peers, matched | $32.82 | $49.57 | $75.09 | +104% |
| Residual income | $10.69 | $11.09 | $11.52 | -54% |
| Analysts' price targets | $24.00 | $26.67 | $30.00 | +10% |
| Owner earnings capitalized | $23.03 | $26.69 | $31.74 | +10% |
Healthcare Services Group's latest quarter
Healthcare Services Group, Q3 2026: revenue $480M (+3% year over year), operating margin 7.0%, net earnings $24.9M, operating cash flow $30.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for HCSG stock?
The median of 6 analysts' 12-month targets is $26.00, +7% from $24.28; the range is $24.00 to $30.00. The average rating is buy.
What is Healthcare Services Group's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $3.80 and $54.06, with a middle value of $26.69 against a price of $24.28. Each method's assumptions are on the page.
Does Healthcare Services Group usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is HCSG stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.